Develops cancer therapies and nononcologic disease treatments.
Jun 2026Revenue $267K/yrExpenses $66.8M/yr
No trend
Figures by year
When will Lite Strategy be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $267K and expenses $66.8M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jun 2026 | $267K | $66.8M | −$66.6M |
| Jun 2025 | $1.03M | $18.5M | −$17.5M |
| Jun 2024 | $65.3M | $50.8M | $14.5M |
| Jun 2023 | $48.8M | $85.6M | −$36.8M |
| Jun 2022 | $40.7M | $116M | −$75.5M |
| Jun 2021 | $34.8M | $95.2M | −$60.4M |
| Jun 2020 | $27.8M | $53.5M | −$25.7M |
| Jun 2019 | $4.92M | $51.2M | −$46.2M |
| Jun 2018 | $1.62M | $30.2M | −$28.6M |
| Jun 2017 | $23.2M | $20.9M | $2.38M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.